1
|
Thurin NH, Grelaud A, Grolleau A, Bernard MA, Bignon E, Blin P, Lassalle R, Droz-Perroteau C. Design and validation of algorithms to identify venous thromboembolism in the French National Healthcare Database. Pharmacoepidemiol Drug Saf 2024; 33:e5781. [PMID: 38527971 DOI: 10.1002/pds.5781] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2023] [Revised: 01/23/2024] [Accepted: 03/12/2024] [Indexed: 03/27/2024]
Abstract
PURPOSE This paper aims to introduce an algorithm designed to identify Venous Thromboembolism (VTE) in the French National Healthcare Database (SNDS) and to estimate its positive predictive value. METHODS A case-identifying algorithm was designed using SNDS inpatient and outpatient encounters, including hospital stays with discharge diagnoses, imaging procedures and drugs dispensed, of French patients aged at least 18 years old to whom baricitinib or Tumor Necrosis Factor Inhibitors (TNFi) were dispensed between September 1, 2017, and December 31, 2018. An intra-database validation study was then conducted, drawing 150 cases identified as VTE by the algorithm and requesting four vascular specialists to assess them. Patient profiles used to conduct the case adjudication were reconstituted from de-identified pooled and formatted SNDS data (i.e., reconstituted electronic health records-rEHR) with a 6-month look-back period prior to the supposed VTE onset and a 12-month follow-up period after. The positive predictive value (PPV) with its 95% confidence interval (95% CI) was calculated as the number of expert-confirmed VTE divided by the number of algorithm-identified VTE. The PPV and its 95% CI were then recomputed among the same patient set initially drawn, once the VTE-identifying algorithm was updated based on expert recommendation. RESULTS For the 150 patients identified with the first VTE-identifying algorithm, the adjudication committee confirmed 92 cases, resulting in a PPV of 61% (95% CI = [54-69]). The final VTE-identifying algorithm including expert suggestions showed a PPV of 92% (95% CI = [86-98]) with a total of 87 algorithm-identified cases, including 80 retrieved from the 92 confirmed by experts. CONCLUSION The identification of VTE in the SNDS is possible with a good PPV.
Collapse
Affiliation(s)
- Nicolas H Thurin
- Bordeaux PharmacoEpi, INSERM CIC-P 1401, University of Bordeaux, Bordeaux, France
| | - Angela Grelaud
- Bordeaux PharmacoEpi, INSERM CIC-P 1401, University of Bordeaux, Bordeaux, France
| | - Adeline Grolleau
- Bordeaux PharmacoEpi, INSERM CIC-P 1401, University of Bordeaux, Bordeaux, France
| | - Marie-Agnès Bernard
- Bordeaux PharmacoEpi, INSERM CIC-P 1401, University of Bordeaux, Bordeaux, France
| | - Emmanuelle Bignon
- Bordeaux PharmacoEpi, INSERM CIC-P 1401, University of Bordeaux, Bordeaux, France
| | - Patrick Blin
- Bordeaux PharmacoEpi, INSERM CIC-P 1401, University of Bordeaux, Bordeaux, France
| | - Régis Lassalle
- Bordeaux PharmacoEpi, INSERM CIC-P 1401, University of Bordeaux, Bordeaux, France
| | | |
Collapse
|
2
|
Bosco‐Lévy P, Briot K, Mehsen‐Cetre N, O'Kelly J, Désaméricq G, Abouelfath A, Lassalle R, Grelaud A, Grolleau A, Blin P, Droz‐Perroteau C. Real-World Effectiveness of Osteoporosis Medications in France: A Nationwide Cohort Study. JBMR Plus 2023; 7:e10789. [PMID: 37701145 PMCID: PMC10494501 DOI: 10.1002/jbm4.10789] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/15/2023] [Revised: 06/01/2023] [Accepted: 06/10/2023] [Indexed: 09/14/2023] Open
Abstract
Although drugs for osteoporosis have been demonstrated to be effective in reducing fracture risk in placebo-controlled clinical trials, data on effectiveness in real-world practice is limited. Data from the French national health insurance claims database (SNDS) were used to follow five cohorts of women aged ≥55 years after initiating treatment for ≥6 months with either denosumab, zoledronic acid, oral bisphosphonates, raloxifene, or teriparatide in 2014-2016. Fracture incidence was compared within each cohort between the 3 months following initiation (baseline fracture risk) and the 12month, 18month, and 24 month postinitiation periods. Data are presented as incidence rate ratios (IRRs) with their 95% confidence intervals (CIs)s. Overall, 67,046 women were included in the denosumab cohort, 52,914 in the oral bisphosphonate cohort, 41,700 in the zoledronic acid cohort, 11,600 in the raloxifene cohort, and 7510 in the teriparatide cohort. The baseline vertebral fracture rate ranged from 1.74 per 1000 person years (‰PY) in the raloxifene cohort to 34.75‰PY in the teriparatide cohort, and the baseline hip fracture rate from 0.70‰PY in the raloxifene cohort to 10.52‰PY in the zoledronic acid cohort. Compared with the baseline fracture rate, vertebral fractures involving hospitalization were significantly reduced in the 3-24-month postinitiation period with denosumab (IRR 0.6; 95% CI, 0.5-0.7), zoledronic acid (IRR 0.4; 95% CI, 0.3-0.4), teriparatide (IRR 0.3; 95% CI, 0.2-0.5), and oral bisphosphonates (IRR 0.6; 95% CI, 0.4-0.8). Hip fracture incidence was reduced with denosumab (IRR 0.8; 95% CI, 0.6-0.9), but higher for oral bisphosphonates (IRR 1.7; 95% CI, 1.2-2.3); no significant change in hip fracture rate was observed for zoledronic acid, teriparatide, or raloxifene. A reduction in nonvertebral, non-hip fracture incidence was observed only in the denosumab cohort (IRR 0.8; 95% CI, 0.7-0.9). These findings indicate that treatment with osteoporosis drugs is effective in the real-world setting. © 2023 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.
Collapse
Affiliation(s)
- Pauline Bosco‐Lévy
- Bordeaux PharmacoEpi, INSERM CIC‐P 1401Université de BordeauxBordeauxFrance
| | - Karine Briot
- Service de rhumatologieHôpital CochinParisFrance
| | | | | | | | | | - Régis Lassalle
- Bordeaux PharmacoEpi, INSERM CIC‐P 1401Université de BordeauxBordeauxFrance
| | - Angela Grelaud
- Bordeaux PharmacoEpi, INSERM CIC‐P 1401Université de BordeauxBordeauxFrance
| | - Adeline Grolleau
- Bordeaux PharmacoEpi, INSERM CIC‐P 1401Université de BordeauxBordeauxFrance
| | - Patrick Blin
- Bordeaux PharmacoEpi, INSERM CIC‐P 1401Université de BordeauxBordeauxFrance
| | | |
Collapse
|
3
|
Grolleau A, Dorchies F, Jourdain N, Ta Phuoc K, Gautier J, Mahieu B, Renaudin P, Recoules V, Martinez P, Lecherbourg L. Femtosecond Resolution of the Nonballistic Electron Energy Transport in Warm Dense Copper. Phys Rev Lett 2021; 127:275901. [PMID: 35061440 DOI: 10.1103/physrevlett.127.275901] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/06/2021] [Revised: 11/03/2021] [Accepted: 12/14/2021] [Indexed: 06/14/2023]
Abstract
The ultrafast electron energy transport is investigated in laser-heated warm dense copper in a high flux regime (2.5±0.7×10^{13} W/cm^{2} absorbed). The dynamics of the electron temperature is retrieved from femtosecond time-resolved x-ray absorption near-edge spectroscopy near the Cu L3 edge. A characteristic time of ∼1 ps is observed for the increase in the average temperature in a 100 nm thick sample. Data are well reproduced by two-temperature hydrodynamic simulations, which support energy transport dominated by thermal conduction rather than ballistic electrons.
Collapse
Affiliation(s)
- A Grolleau
- CEA, DAM, DIF, F-91297 Arpajon, France
- Université Bordeaux, CNRS, CEA, CELIA, UMR 5107, F-33400 Talence, France
| | - F Dorchies
- Université Bordeaux, CNRS, CEA, CELIA, UMR 5107, F-33400 Talence, France
| | - N Jourdain
- CEA, DAM, DIF, F-91297 Arpajon, France
- Université Bordeaux, CNRS, CEA, CELIA, UMR 5107, F-33400 Talence, France
| | - K Ta Phuoc
- LOA, ENSTA, CNRS UMR 7639, Institut Polytechnique de Paris, F-91761 Palaiseau, France
| | - J Gautier
- LOA, ENSTA, CNRS UMR 7639, Institut Polytechnique de Paris, F-91761 Palaiseau, France
| | - B Mahieu
- LOA, ENSTA, CNRS UMR 7639, Institut Polytechnique de Paris, F-91761 Palaiseau, France
| | | | | | - P Martinez
- Université Bordeaux, CNRS, CEA, CELIA, UMR 5107, F-33400 Talence, France
| | - L Lecherbourg
- CEA, DAM, DIF, F-91297 Arpajon, France
- LOA, ENSTA, CNRS UMR 7639, Institut Polytechnique de Paris, F-91761 Palaiseau, France
| |
Collapse
|
4
|
Misdrahi D, Tournier M, Droulout T, Grolleau A, Titier K, Molimard M, Verdoux H. Efficiency and safety of oxcarbazepine in mood disorders: A naturalistic study exploring the interest of plasma dosages. Eur Psychiatry 2020; 23:409-12. [DOI: 10.1016/j.eurpsy.2008.05.003] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/17/2007] [Revised: 04/21/2008] [Accepted: 05/20/2008] [Indexed: 10/21/2022] Open
Abstract
AbstractObjectiveTo investigate whether measurement of plasma levels can predict tolerance to oxcarbazepine (OXC).MethodsWe reviewed medical records to identify all inpatients consecutively treated by OXC at the University Department of Psychiatry in Bordeaux. Adverse effects were rated before treatment onset, at day 3, then every week and at discharge or at discontinuation. Residual hydroxy-OXC concentrations were measured on blood samples at the same periods.ResultsOXC was prescribed to 20 patients with bipolar (n = 18) or schizoaffective bipolar-type disorder (n = 2). Reported side effects were transient and occurred mostly at the beginning of the treatment. Three patients stopped OXC because of severe cutaneous side effects. Residual hydroxy-OXC plasma levels were similar in patients with or without occurrence of side effects at all times of assessment.ConclusionOur data suggest that the occurrence of severe side-effects is relatively high with OXC. Measurement of plasma OXC levels does not appear to be of interest in clinical practice since plasma concentrations are not predictive of the occurrence of side effects.
Collapse
|
5
|
Moore N, Grolleau A, Duret S, Thurin N, Duong M, Lassalle R, Blin P, Gulmez SE, Droz-Perroteau C. Hospitalisation pour hépatite aiguë et exposition aux anti-inflammatoires non stéroïdiens et aux analgésiques. Rev Epidemiol Sante Publique 2019. [DOI: 10.1016/j.respe.2019.04.043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
|
6
|
Grolleau A, Duret S, Thurin N, Duong M, Lassalle R, Blin P, Droz-Perroteau C, Gulmez SE, Moore N. Hospitalisation pour hépatite aiguë et exposition aux antidépresseurs et benzodiazépines. Rev Epidemiol Sante Publique 2019. [DOI: 10.1016/j.respe.2019.04.044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
|
7
|
Gulmez SE, Unal US, Lassalle R, Chartier A, Grolleau A, Moore N. Risk of hospital admission for liver injury in users of NSAIDs and nonoverdose paracetamol: Preliminary results from the EPIHAM study. Pharmacoepidemiol Drug Saf 2018; 27:1174-1181. [PMID: 30112779 DOI: 10.1002/pds.4640] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2017] [Revised: 07/12/2018] [Accepted: 07/17/2018] [Indexed: 12/12/2022]
Abstract
PURPOSE The SALT study found similar per-user risks of acute liver failure (ALF) leading to transplantation (ALFT) between NSAIDs and a threefold higher risk in nonoverdose paracetamol (NOP) users. The objective of EPIHAM was to identify the risks of hospital admission for acute liver injury (ALI) associated with NSAIDs and NOP. METHODS Case-population study in the 1/97 sample of the French population claims database. Acute liver injury was identified from hospital discharge summaries, from 2009 to 2013. Exposure for cases was dispensing of NSAID or NOP resulting in exposure within 30 days before admission. Population exposure was the number of patients using the drugs over the study timeframe and total number of DDD dispensed. RESULTS Of 63 cases of ALI, 13 had been exposed to NSAIDs and 24 to NOP. Events per million DDD (95% CI) ranged from 0.46 (0.09-1.34) (ketoprofen) to 1.43 (0.04-7.97) (diclofenac combinations), 0.43 (0.23-0.73) all NSAIDs combined, 0.58 (0.37-0.86) for NOP. There was no association with average duration of treatment. Per patient risk ranged from 19.5 (5.31-49.9) (ibuprofen) per million users to 37.2 (19.8-63.6) all NSAIDs combined, 58.0 (37.2-86.3) for NOP. There was a linear relationship between average treatment duration and per-user risk (R2 = 0.51, P < .05 for NSAIDs, R2 = 0.97, P < .01 for NOP). CONCLUSIONS Risk of hospital admission for ALI with NSAIDs and NOP was similar and indicative of a dose and duration-related effect (pharmacological) effect. Acute liver injury rates were not predictive of ALFT risk.
Collapse
Affiliation(s)
- Sinem Ezgi Gulmez
- Bordeaux PharmacoEpi, INSERM CIC1401, Université de Bordeaux, Bordeaux, France
| | - Ulku Sur Unal
- Tekirdağ Çerkezköy Tepe Emlak Family Medicine Centre,, Cumhuriyet District Tepe Emlak Part 2, Çerkezköy-Tekirdağ, Turkey
| | - Régis Lassalle
- Bordeaux PharmacoEpi, INSERM CIC1401, Université de Bordeaux, Bordeaux, France
| | - Anaïs Chartier
- Bordeaux PharmacoEpi, INSERM CIC1401, Université de Bordeaux, Bordeaux, France
| | - Adeline Grolleau
- Bordeaux PharmacoEpi, INSERM CIC1401, Université de Bordeaux, Bordeaux, France
| | - Nicholas Moore
- Bordeaux PharmacoEpi, INSERM CIC1401, Université de Bordeaux, Bordeaux, France
| |
Collapse
|
8
|
Blin P, Delcourt C, Massin P, Guillausseau PJ, Creuzot-Garcher C, Kodjikian L, Lassalle R, Chartier A, Bernard MA, Hamoud F, Maizi H, Finzi L, Droz-Perroteau C, Grolleau A, Grelaud A, Moore N. Efficacité en vie réelle du traitement par injection intravitréenne de ranibizumab pour une baisse de l’acuité visuelle due à un œdème maculaire diabétique : la cohorte BOREAL. Rev Epidemiol Sante Publique 2017. [DOI: 10.1016/j.respe.2017.04.035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
|
9
|
Grolleau A, Barbet V, Thurin N, Lassalle R, Duong M, Droz-Perroteau C, Moore N. Risque populationnel et risque individuel d’hospitalisation pour hépatite aiguë médicamenteuse à partir des données de l’assurance maladie (Sniiram). Rev Epidemiol Sante Publique 2017. [DOI: 10.1016/j.respe.2017.04.043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
|
10
|
Blin P, Delcourt C, Glacet-Bernard A, Fajnkuchen F, Girmens JF, Lassalle R, Chartier A, Bernard MA, Diez P, Douina N, Le Monies de Sagazan A, Finzi L, Droz-Perroteau C, Grolleau A, Grelaud A, Moore N. Efficacité en vie réelle du traitement par injection intravitréenne de ranibizumab pour une baisse de l’acuité visuelle due à un œdème maculaire secondaire à une occlusion veineuse rétinienne : les cohortes BOREAL. Rev Epidemiol Sante Publique 2017. [DOI: 10.1016/j.respe.2017.04.034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
|
11
|
Ezgi Gulmez S, Lassalle R, Jové J, Grolleau A, Moore. N. Risque d’hospitalisation pour hépatite chez les utilisateurs d’AINS et de paracétamol sans surdosage (EPIHAM). Rev Epidemiol Sante Publique 2016. [DOI: 10.1016/j.respe.2016.04.021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
12
|
Gulmez S, Lassalle R, Jové J, Caridade G, Grolleau A, Moore N. Risk of hospital admission for Liver injury in users of nsaids and non-overdose paracetamol (EPIHAM). Clin Ther 2015. [DOI: 10.1016/j.clinthera.2015.05.053] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
13
|
Jacquet A, Grolleau A, Jove J, Lassalle R, Moore N. Burnout: Evaluation of the efficacy and tolerability of TARGET 1® for professional fatigue syndrome (burnout). J Int Med Res 2014; 43:54-66. [DOI: 10.1177/0300060514558324] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Objective To study the effect of a dietary supplement (TARGET 1®: a combination of casozepine, taurine, Eleutherococcus senticosus and extramel) on burnout symptomatology. Methods A 12-week, double-blind, randomized, placebo-controlled trial was conducted in workers engaged in professional contact with patients, students or clients. All were affected by burnout syndrome based on a score of ≥4 on the Burnout Measure Scale (BMS-10). The primary outcome measure was the change in the BMS-10 score; secondary outcome measures included the change in the Maslach’s Burnout Inventory scale-Human Service Survey (MBI-HSS) score and the Beck Depression Inventory. Five scores were evaluated. Results Eighty-seven participants were enrolled in the study: 44 received the active formulation (verum group); 43 received placebo. After 12 weeks’ supplementation, the placebo group showed significant improvements in scores for BMS-10, MBI-HSS fatigue and the Beck Depression Inventory, but MBI-HSS depersonalization and task management were not improved; the verum group showed significant improvements in all five scores. The verum group consistently showed significantly greater improvements in scores than the placebo group. Conclusions TARGET 1® significantly improved the symptoms of burnout after 12 weeks’ use.
Collapse
Affiliation(s)
- Alain Jacquet
- Department of Clinical Pharmacology, University of Bordeaux Ségalen, Bordeaux, France
| | - Adeline Grolleau
- Department of Clinical Pharmacology, University of Bordeaux Ségalen, Bordeaux, France
- INSERM CIC-P0005, Bordeaux, France
| | - Jérémy Jove
- INSERM CIC-P0005, Bordeaux, France
- ADERA, Pessac, France
| | | | - Nicholas Moore
- Department of Clinical Pharmacology, University of Bordeaux Ségalen, Bordeaux, France
- INSERM CIC-P0005, Bordeaux, France
- INSERM U657, Bordeaux, France
| |
Collapse
|
14
|
Blin P, Dureau-Pournin C, Foubert-Samier A, Grolleau A, Corbillon E, Jové J, Lassalle R, Robinson P, Poutignat N, Droz-Perroteau C, Moore N. Parkinson's disease incidence and prevalence assessment in France using the national healthcare insurance database. Eur J Neurol 2014; 22:464-71. [PMID: 25389031 DOI: 10.1111/ene.12592] [Citation(s) in RCA: 42] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2014] [Accepted: 09/10/2014] [Indexed: 11/29/2022]
Abstract
BACKGROUND AND PURPOSE The incidence and prevalence of Parkinson's disease are important for public health planning yet there is a lack of representative, up-to-date estimations for France. METHODS For this cross-sectional study, subjects with suspected Parkinson's were identified in the EGB database, a 1/97 random sample of the national healthcare insurance database, linked to the national hospital-discharge summary database. Incidence and prevalence were estimated using a specific definition that included those with a diagnosis (hospitalization or listed as a long-term chronic disease for full reimbursement) and a sensitive definition that also included those with an indicative drug reimbursement profile. Estimations were extrapolated to the national population, standardizing on age and gender. RESULTS According to either the specific or the sensitive definitions, the annual incidence of Parkinson's disease during the study period was respectively 36 and 49 per 100,000 person-years and prevalence in 2010 was 308-410 per 100,000 persons in the population as a whole. According to the age groups 55-64, 65-74, 75-84 and ≥85 years incidence was respectively 33-46, 139-172, 301-363 and 442-560 per 100,000 person-years amongst men and 32-55, 81-117, 203-270 and 251-313 per 100,000 person-years amongst women. The 2010 prevalence stratified by the same age groups was 293-376, 898-1161, 2524-3011 and 3760-4578 per 100,000 persons amongst men and 199-351, 618-889, 1910-2433 and 2504-3263 per 100,000 persons amongst women. CONCLUSIONS The specific and sensitive definitions of disease bracket the true values; the relatively small range indicates that the current study provides good estimations of incidence and prevalence of Parkinson's disease for recent years in France.
Collapse
Affiliation(s)
- P Blin
- Adera, Pessac, France; CIC Bordeaux CIC1401, Bordeaux, France
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
15
|
Blin P, Dureau C, Lamarque S, Bernard MA, Robinson P, Lassalle R, Grolleau A, Droz C, Moore N. Misuse, Abuse, and Diversion of instanyl® (Fentanyl Nasal Spray) in France. Value Health 2014; 17:A649. [PMID: 27202339 DOI: 10.1016/j.jval.2014.08.2357] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Affiliation(s)
- P Blin
- INSERM CIC Bordeaux CIC1401, Univ. Bordeaux, Bordeaux, France
| | - C Dureau
- INSERM CIC Bordeaux CIC1401, Univ. Bordeaux, Bordeaux, France
| | - S Lamarque
- INSERM CIC Bordeaux CIC1401, Univ. Bordeaux, Bordeaux, France
| | - M A Bernard
- INSERM CIC Bordeaux CIC1401, Univ. Bordeaux, Bordeaux, France
| | - P Robinson
- INSERM CIC Bordeaux CIC1401, Univ. Bordeaux, Bordeaux, France
| | - R Lassalle
- INSERM CIC Bordeaux CIC1401, Univ. Bordeaux, Bordeaux, France
| | - A Grolleau
- INSERM CIC Bordeaux CIC1401, Univ. Bordeaux, Bordeaux, France
| | - C Droz
- INSERM CIC Bordeaux CIC1401, Univ. Bordeaux, Bordeaux, France
| | - N Moore
- INSERM CIC Bordeaux CIC1401, Univ. Bordeaux, INSERM U657, CHU Bordeaux, Bordeaux, France
| |
Collapse
|
16
|
Blin P, Dureau C, Grolleau A, Corbillon E, Jové J, Lassalle R, Poutignac N, Foubert-Samier A, Droz C, Moore N. Estimation de la prévalence et de l’incidence de la maladie de Parkinson en France à partir de l’échantillon généraliste des bénéficiaires. Rev Epidemiol Sante Publique 2014. [DOI: 10.1016/j.respe.2014.05.076] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
17
|
Blin P, Dureau C, Lamarque S, Bernard MA, Robinson P, Lassalle R, Grolleau A, Droz C, Moore N. Mésusage, abus et détournement d’Instanyl® (fentanyl par voie nasale) en France. Rev Epidemiol Sante Publique 2014. [DOI: 10.1016/j.respe.2014.05.078] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
18
|
Blin P, Dureau C, Grolleau A, Corbillon E, Jové J, Lassalle R, Poutignat N, Foubert-Samier A, Droz C, Moore N. Estimation de la prévalence et de l’incidence de la maladie de Parkinson en France à partir de l’Échantillon généraliste de bénéficiaires. Rev Epidemiol Sante Publique 2014. [DOI: 10.1016/j.respe.2013.11.054] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
19
|
Gin H, Demeaux JL, Grelaud A, Grolleau A, Droz-Perroteau C, Robinson P, Lassalle R, Abouelfath A, Boisseau M, Toussaint C, Moore N. Observation of the long-term effects of lifestyle intervention during balneotherapy in metabolic syndrome. Therapie 2013; 68:163-7. [PMID: 23886461 DOI: 10.2515/therapie/2013025] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2012] [Accepted: 01/29/2013] [Indexed: 11/20/2022]
Abstract
OBJECTIVE Estimate the effect of lifestyle adjustment activities in patients with metabolic syndrome treated by prescribed balneotherapy. METHODS Observational pilot cohort study with 12-month follow-up after multidimensional lifestyle training (physical, dietary, educational) during 3-week standard stay in the spa town of Eugénie-les-Bains. RESULTS Of 145 eligible patients, 97 were included; 63 were followed and analysable. At inclusion all had ≥3 National cholesterol education program-Adult treatment panel III (NCEP-ATPIII) criteria defining metabolic syndrome, 76.2% were female, mean age was 61.2 years. At the end of follow-up (median:10.4 months, Inter-Quartile Range: [6.7;11.4]), 48 of these 63 patients (76.2%) no longer had metabolic syndrome (95%CI [65.7;86.7]). These 48 patients without metabolic syndrome at the end of follow-up represented 49.5% of the 97 included (95%CI [39.5;59.4]). CONCLUSIONS Future studies of lifestyle interventions taking advantage of the spa environment can be expected to find least one third of patients free of metabolic syndrome at the end of 12-month follow-up in the intervention group.
Collapse
Affiliation(s)
- Henri Gin
- Université de Bordeaux, Bordeaux, France
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
20
|
Grelaud A, Grolleau A, Demeaux JL, Abouelfath A, Boisseau MR, Lassalle R, Toussaint C, Robinson P, Guérard M, Droz-Perroteau C, Gin H, Moore N. Résultats de Prisme ; une étude pilote sur l’effet à un an d’une prise en charge multidisciplinaire du syndrome métabolique. Rev Epidemiol Sante Publique 2011. [DOI: 10.1016/j.respe.2011.08.054] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
21
|
Cougnard A, Verdoux H, Grolleau A, Moride Y, Begaud B, Tournier M. Impact of antidepressants on the risk of suicide in patients with depression in real-life conditions: a decision analysis model. Psychol Med 2009; 39:1307-1315. [PMID: 19063772 DOI: 10.1017/s003329170800473x] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
BACKGROUND The impact of antidepressant drug treatment (ADT) on the risk of suicide is uncertain. The aim of this study was to determine in a real-life setting whether ADT is associated with an increased or a reduced risk of suicide compared to absence of ADT (no-ADT) in patients with depression. METHOD A decision analysis method was used to estimate the number of suicides prevented or induced by ADT in children and adolescents (10-19 years old), adults (20-64 years old) and the elderly (65 years) diagnosed with major depression. The impact of gender and parasuicide history on the findings was explored within each age group. Sensitivity analyses were used to assess the robustness of the models. RESULTS Prescribing ADT to all patients diagnosed with depression would prevent more than one out of three suicide deaths compared to the no-ADT strategy, irrespective of age, gender or parasuicide history. Sensitivity analyses showed that persistence in taking ADT would be the main characteristic influencing the effectiveness of ADT on suicide risk. CONCLUSIONS Public health decisions that contribute directly or indirectly to reducing the number of patients with depression who are effectively administered ADT may paradoxically induce a rise in the number of suicides.
Collapse
Affiliation(s)
- A Cougnard
- University Victor Segalen Bordeaux 2, INSERM U657, IFR of Public Health, Bordeaux, France
| | | | | | | | | | | |
Collapse
|
22
|
Tournier M, Grolleau A, Cougnard A, Verdoux H, Molimard M. The Prognostic Impact of Psychotropic Drugs in Intentional Drug Overdose. Pharmacopsychiatry 2009; 42:51-6. [DOI: 10.1055/s-0028-1100426] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
23
|
Tournier M, Grolleau A, Cougnard A, Molimard M, Verdoux H. Choice of Psychotropic Drugs Used for Intentional Drug Overdose. Eur Psychiatry 2009. [DOI: 10.1016/s0924-9338(09)71048-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
Abstract
Objectives:To assess with which frequency subjects with intentional overdose of psychotropic drugs ingest their own psychotropic drug treatment, and whether prescription of a drug may be a factor influencing the choice of drugs used for the IDO.Methods:Demographic characteristics, psychiatric history, and currently prescribed psychotropic drug treatment were collected for all the patients (n=1654) admitted to an emergency department (ED) for IDO with psychotropic drugs (anxiolytics, hypnotics, antidepressants, antipsychotics and mood stabilizers) over a period of 18 months.Results:Two-thirds of the patients ingested during the IDO at least one of their own prescribed psychotropic drugs. Compared with the subjects who had ingested psychotropic drugs not prescribed for them, they were more likely to have a history of psychiatric hospitalization (OR 4.2; 95%CI 3.1-5.5), of parasuicide (OR 2.5; 95%CI 1.9-3.3), to be a psychiatric outpatient (OR 3.9; 95%CI 3.0-5.1), and to present with a serious IDO (OR 2; 95%CI 1.4-2.9). Independently from age and psychiatric hospitalization history (i.e. the seriousness of psychiatric disorder), they ingested during the IDO more often antidepressants (OR 4.4; 95%CI 3.0-6.4), antipsychotics (OR 2.9; 95%CI 1.7-4.8) and mood stabilizers (OR 4.1; 95%CI 1.6-10.7). No association was found with prescription for overdose of benzodiazepine or paracetamol.Conclusion:Prescription of the psychotropic drugs plays an important role in the choice of the drugs ingested for the IDO. It might make potentially “dangerous” drugs available for the patient. Physicians have always to balance the benefit of the treatment against the risk of drug overdose.
Collapse
|
24
|
Grolleau A, Cougnard A, Bégaud B, Verdoux H. Congruence between diagnosis of recurrent major depressive disorder and psychotropic treatment in the general population. Acta Psychiatr Scand 2008; 117:20-7. [PMID: 17970841 DOI: 10.1111/j.1600-0447.2007.01109.x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
OBJECTIVE We explored in a sample representative of the French general population the congruence between lifetime use of psychotropic drugs and diagnosis of recurrent major depressive disorder (rMDD). METHOD A total of 2111 (5.6%) subjects with rMDD were identified in the sample of 36 785 subjects assessed in the Mental Health survey in the General Population. A treatment congruent with a diagnosis of rMDD was defined as lifetime use of antidepressants or mood stabilizers. RESULTS Only one-third of subjects with rMDD reported having ever used a congruent treatment. Female gender, higher income and presence of anxiety disorder were associated with a higher probability of having used a congruent treatment. CONCLUSION Although these findings indicate that a large proportion of subjects with rMMD do not benefit from adequate treatment, community surveys not primarily designed to assess utilization and adequacy of psychotropic treatment in the community may overestimate the frequency of unmet need for care.
Collapse
Affiliation(s)
- A Grolleau
- University Victor Segalen Bordeaux 2, Bordeaux, France
| | | | | | | |
Collapse
|
25
|
Grolleau A, Cougnard A, Parrot M, Kalmi E, Desage A, Misdrahi D, Brun-Rousseau H, Verdoux H. [Prescription practices of antipsychotic medication in early psychosis: a two-year follow-up survey of subjects admitted in two psychiatric hospitals of South-Western France]. Encephale 2007; 33:326-31. [PMID: 17675930 DOI: 10.1016/s0013-7006(07)92046-1] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
OBJECTIVES The aims of this pharmacoepidemiological study were to describe the antipsychotic medication received during the first admission and over a two-year follow-up in subjects with a first episode of psychosis, and to assess whether the prescriptions in naturalistic conditions were in adequacy with guidelines. METHOD All first-admitted patients, less than 50 years old, consecutively hospitalised in 10 acute wards of two psychiatric hospitals serving Bordeaux's catchment area were included over a period of one year, if they presented with at least one overt psychotic symptom during the last month. Information on psychotropic medication received during the first admission was collected in medical records, and that received after the first admission was collected at the end of a two-year follow-up using multiple sources of information. RESULTS Of the 86 patients included in the cohort, 53 presented with broadly defined schizophrenia and 33 with psychotic mood disorder. All except two subjects were prescribed at least one neuroleptic drug. Antipsychotic drugs (amisulpride, olanzapine, risperidone, clozapine) were the most frequently prescribed drugs during the first admission and over the two-year follow-up. If sedative neuroleptics were excluded, antipsychotic drugs were the first prescribed neuroleptic drugs in a large proportion (80%) of patients. Although few patients were first prescribed a conventional neuroleptic, the proportion of subjects treated with these drugs increased over the next prescriptions, and one out of three patients was prescribed at least one of these drugs during the follow-up. The mean dose of antipsychotic drugs at first discharge was higher than that recommended in first episode patients (amisulpride 616 mg, olanzapine 13 mg, risperidone 7 mg). Coprescription of neuroleptic drugs, found in one third of patients at all times of assessment, was especially due to coprescription of a sedative neuroleptic to a conventional or an antipsychotic one. Nearly half of the patients did not take any psychotropic medication at the end of the follow-up. CONCLUSION The main recommendation specifying that the first neuroleptic treatment in subjects with a first episode of psychosis should use antipsychotic drugs instead of conventional neuroleptics was generally respected in this cohort of first-admitted subjects with psychosis. However, conventional neuroleptics were found in first or second rank prescriptions, although they should not be used before at least the third rank. The recommendations that the initial neuroleptic dose should be lower in subjects with a first episode, and that coprescription of neuroleptics should be avoided, were frequently not respected. This study highlights the fact that international guidelines should be better applied in naturalistic conditions, and that clinicians have to be better informed about these recommendations.
Collapse
Affiliation(s)
- A Grolleau
- Université Victor-Segalen Bordeaux 2, Bordeaux, France
| | | | | | | | | | | | | | | |
Collapse
|
26
|
|
27
|
Le Naour F, Hohenkirk L, Grolleau A, Misek DE, Lescure P, Geiger JD, Hanash S, Beretta L. Profiling changes in gene expression during differentiation and maturation of monocyte-derived dendritic cells using both oligonucleotide microarrays and proteomics. J Biol Chem 2001; 276:17920-31. [PMID: 11279020 DOI: 10.1074/jbc.m100156200] [Citation(s) in RCA: 224] [Impact Index Per Article: 9.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
Dendritic cells (DCs) are antigen-presenting cells that play a major role in initiating primary immune responses. We have utilized two independent approaches, DNA microarrays and proteomics, to analyze the expression profile of human CD14(+) blood monocytes and their derived DCs. Analysis of gene expression changes at the RNA level using oligonucleotide microarrays complementary to 6300 human genes showed that approximately 40% of the genes were expressed in DCs. A total of 255 genes (4%) were found to be regulated during DC differentiation or maturation. Most of these genes were not previously associated with DCs and included genes encoding secreted proteins as well as genes involved in cell adhesion, signaling, and lipid metabolism. Protein analysis of the same cell populations was done using two-dimensional gel electrophoresis. A total of 900 distinct protein spots were included, and 4% of them exhibited quantitative changes during DC differentiation and maturation. Differentially expressed proteins were identified by mass spectrometry and found to represent proteins with Ca(2+) binding, fatty acid binding, or chaperone activities as well as proteins involved in cell motility. In addition, proteomic analysis provided an assessment of post-translational modifications. The chaperone protein, calreticulin, was found to undergo cleavage, yielding a novel form. The combined oligonucleotide microarray and proteomic approaches have uncovered novel genes associated with DC differentiation and maturation and has allowed analysis of post-translational modifications of specific proteins as part of these processes.
Collapse
Affiliation(s)
- F Le Naour
- Department of Microbiology, University of Michigan, Ann Arbor, Michigan 48109-0666, USA
| | | | | | | | | | | | | | | |
Collapse
|
28
|
Grolleau A, Kaplan MJ, Hanash SM, Beretta L, Richardson B. Impaired translational response and increased protein kinase PKR expression in T cells from lupus patients. J Clin Invest 2000; 106:1561-8. [PMID: 11120763 PMCID: PMC381471 DOI: 10.1172/jci9352] [Citation(s) in RCA: 41] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
Activation of peripheral blood T cells results in a rapid and substantial rise in translation rates and proliferation, but proliferation in response to mitogen stimulation is impaired in systemic lupus erythematosus (SLE). We have investigated translation rates and initiation factor activities in T cells from SLE patients in response to activating signals. Activation by PMA plus ionomycin strongly increased protein synthesis in control T cells but not in T cells from SLE patients. The rate of protein synthesis is known to be strongly dependent on the activity of two eukaryotic translation initiation factors, eIF4E and eIF2alpha. We show that following stimulation, eIF4E expression and phosphorylation increased equivalently in control and SLE T cells. Expression of eIF4E interacting proteins - eIF4G, an inducer, and 4E-BP1 and 4E-BP2, two specific repressors of eIF4E function - and the phosphorylation level of 4E-BP1, were all identical in control and SLE T cells. In contrast, the protein kinase PKR, which is responsible for the phosphorylation and consequent inhibition of eIF2alpha activity, was specifically overexpressed in activated SLE T cells, correlating with an increase in eIF2alpha phosphorylation. Therefore, high expression of PKR and subsequent eIF2alpha phosphorylation is likely responsible, at least in part, for impaired translational and proliferative responses to mitogens in T cells from SLE patients.
Collapse
Affiliation(s)
- A Grolleau
- Institut National de la Santé et de la Recherche Médicale (INSERM), Unité 365, Institut Curie, Paris, France
| | | | | | | | | |
Collapse
|
29
|
Grolleau A, Wietzerbin J, Beretta L. Defect in the regulation of 4E-BP1 and 2, two repressors of translation initiation, in the retinoid acid resistant cell lines, NB4-R1 and NB4-R2. Leukemia 2000; 14:1909-14. [PMID: 11069026 DOI: 10.1038/sj.leu.2401904] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
We recently reported evidence for differential regulation of the translation machinery during human myeloid differentiation, specific to the monocytic/macrophage pathway or to the granulocytic pathway. A decrease in translation rates and concomitant regulation of two repressors of translation initiation, 4E-BP1 and 4E-BP2 (eIF4E-binding proteins 1 and 2), occur in cells induced to differentiate along the monocytic/macrophage pathway or along the granulocytic pathway. Induction of HL-60 and U-937 cell differentiation into monocytes/macrophages results in a dephosphorylation and consequent activation of 4E-BP1. In contrast, following treatment of HL-60 cells with retinoic acid (RA) which results in a granulocytic differentiation of these cells, 4E-BP1 protein expression is decreased whereas 4E-BP2 protein expression is strongly increased. In this study, we further investigated the regulation of 4E-BP1 and 4E-BP2 in the RA-induced differentiation process using the NB4 promyelocytic cell line and the RA maturation-resistant NB4 subclones, NB4-R1 and NB4-R2. RA treatment resulted in a decrease in 4E-BP1 protein and mRNA expression and concomitant increase in 4E-BP2 protein expression, in NB4 cells, but not in NB4-R1 and NB4-R2 cells. The increase in 4E-BP2 protein expression was not correlated to an increase in 4E-BP2 mRNA level suggesting a post-transcriptional regulation of 4E-BP2 expression. In RA-primed cells, cAMP induce maturation of NB4-R1, but not NB4-R2 cells. cAMP treatment resulted in a down-regulation of 4E-BP1 protein and mRNA expression in RA-primed NB4-R1, but not NB4-R2 cells. However, 4E-BP2 expression was not modified in both cell types following cAMP treatment. This indicates that 4E-BP1 down-regulation is associated with granulocytic maturation, whereas post-transcriptional regulation of 4E-BP2 expression is associated with the early action of RA.
Collapse
MESH Headings
- Adaptor Proteins, Signal Transducing
- Antineoplastic Agents/pharmacology
- Carrier Proteins/biosynthesis
- Carrier Proteins/genetics
- Cell Cycle Proteins
- Cell Differentiation/drug effects
- Clone Cells/drug effects
- Clone Cells/metabolism
- Cyclic AMP/analogs & derivatives
- Cyclic AMP/pharmacology
- Drug Resistance, Neoplasm
- Eukaryotic Initiation Factors
- Gene Expression Regulation, Leukemic/drug effects
- Granulocytes
- Humans
- Leukemia, Promyelocytic, Acute/genetics
- Leukemia, Promyelocytic, Acute/pathology
- Myeloid Progenitor Cells/drug effects
- Myeloid Progenitor Cells/metabolism
- Neoplasm Proteins/biosynthesis
- Neoplasm Proteins/genetics
- Peptide Chain Initiation, Translational
- Peptide Initiation Factors/biosynthesis
- Peptide Initiation Factors/genetics
- Phosphoproteins/biosynthesis
- Phosphoproteins/genetics
- RNA Processing, Post-Transcriptional
- RNA, Messenger/biosynthesis
- RNA, Neoplasm/biosynthesis
- Repressor Proteins/biosynthesis
- Repressor Proteins/genetics
- Second Messenger Systems
- Thionucleotides/pharmacology
- Tretinoin/pharmacology
- Tumor Cells, Cultured/drug effects
- Tumor Cells, Cultured/metabolism
Collapse
Affiliation(s)
- A Grolleau
- INSERM U.365, Institut Curie, Paris, France
| | | | | |
Collapse
|
30
|
Grolleau A, Sonenberg N, Wietzerbin J, Beretta L. Differential regulation of 4E-BP1 and 4E-BP2, two repressors of translation initiation, during human myeloid cell differentiation. J Immunol 1999; 162:3491-7. [PMID: 10092805] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/11/2023]
Abstract
Human myeloid differentiation is accompanied by a decrease in cell proliferation. Because the translation rate is an important determinant of cell proliferation, we have investigated translation initiation during human myeloid cell differentiation using the HL-60 promyelocytic leukemia cell line and the U-937 monoblastic cell line. A decrease in the translation rate is observed when the cells are induced to differentiate along the monocytic/macrophage pathway or along the granulocytic pathway. The inhibition in protein synthesis correlates with specific regulation of two repressors of translation initiation, 4E-BP1 and 4E-BP2. Induction of HL-60 and U-937 cell differentiation into monocytes/macrophages by IFN-gamma or PMA results in a dephosphorylation and consequent activation of 4E-BP1. Dephosphorylation of 4E-BP1 was also observed when U-937 cells were induced to differentiate into monocytes/macrophages following treatment with retinoic acid or DMSO. In contrast, treatment of HL-60 cells with retinoic acid or DMSO, which results in a granulocytic differentiation of these cells, decreases 4E-BP1 amount without affecting its phosphorylation and strongly increases 4E-BP2 amount. Taken together, these data provide evidence for differential regulation of the translational machinery during human myeloid differentiation, specific to the monocytic/macrophage pathway or to the granulocytic pathway.
Collapse
Affiliation(s)
- A Grolleau
- Institut National de la Santé et de la Recherche Médicale, U.365, Institut Curie, Paris, France
| | | | | | | |
Collapse
|
31
|
Beretta L, Grolleau A. La rapamycine : identification d'une nouvelle voie de signalisation des facteurs de croissance, réglant le début de la traduction. Med Sci (Paris) 1998. [DOI: 10.4267/10608/1099] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|